• Viewpoint: 'Pharmacy desert' definition is ripe for revision

    Time traveled is a better indicator than distance traveled in determining what constitutes a pharmacy desert, Yale and Weill Cornell researchers argue in a July 29 opinion piece in The Hill.
  • COVID-19 nasal vaccine: 3 notes

    In a July 26 federal summit about the future of COVID-19 treatments, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, highlighted the importance of developing nasal vaccines. 
  • Amazon's threat to retail pharmacies: 3 findings

    The retail pharmacy industry is facing increased competition from online retailers such as Amazon, according to the J.D. Power 2022 "U.S. Pharmacy Study" released July 28.
  • Cheshire Medical Center keeps pharmacy permit, with restrictions

    Cheshire Medical Center in Keene, N.H., part of Dartmouth Health, on July 28 reached a settlement with the state's pharmacy board that allows it to keep its pharmacy permit, with various restrictions that will last for three years, The Keene Sentinel reported Aug. 1.
  • Nation's 1st case over right to contraception begins in Minnesota

    In a post-Roe America, a Minnesota jury is tasked to decide this week whether people have the right to emergency contraception in what is thought to be the first case of its kind, according to the Star Tribune.
  • Lab capacity far exceeds monkeypox tests despite rising cases

    Despite labs ramping up their production to assess thousands of monkeypox tests per week, some labs are receiving a scarce number of tests, according to CNN.
  • Legislators urge Walgreens to change reproductive product policy

    After an alleged incident of a Walgreens worker refusing to sell condoms spurred a barrage of calls for a boycott, U.S. Sens. Dick Durbin and Tammy Duckworth of Illinois pressed the retail pharmacy to renew its policies.
  • Rite Aid denies some prescriptions from telehealth startups

    Rite Aid Corp. has stopped filling prescriptions for controlled substances from the telehealth startups Cerebral and Done, Bloomberg reported July 28.
  • US to buy 66M doses of Moderna's omicron-targeted vaccine 

    HHS, in collaboration with the U.S. Department of Defense, will purchase 66 million doses of Moderna's bivalent COVID-19 vaccine booster for potential use later this year.
  • Attorney general files suit accusing CVS of antitrust law violations

    New York Attorney General Letitia James is suing CVS Health for allegedly violating antitrust laws and "diverting millions from underserved communities," according to a July 28 news release. 
  • Pfizer earned $27.7B in Q2: 3 findings

    In 2022's second quarter, Pfizer reported July 28 its largest-ever quarterly sales as it racked up $27.7 billion, mostly thanks to its vaccine sales. 
  • 90% of Americans live close to a pharmacy, analysis finds

    Nearly 9 of every 10 Americans live within 5 miles of a pharmacy, and about 50 percent of the population lives within 1 mile of one, according to a preprint analysis. 
  • Critics say Mark Cuban's pharmacy isn't tackling the big issue: brand-name drugs

    Mark Cuban's pharmacy, Cost Plus Drug Co., has hundreds of drugs marked at discounted prices, but some pharmacy experts say there's a larger problem that needs fixing, CNBC reported July 28. 
  • 10 hospitals seeking pharmacy leaders

    The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.
  • Top 15 specialty pharmacies by revenue

    CVS Health's and Cigna's specialty pharmacies make a slight majority in the nation's revenue share, and the four top companies account for 75 percent of the market share, according to the Drug Channels Institute's estimates released July 27. 
  • Officials push for omicron-targeted vaccines by September

    Refreshed vaccines aimed at omicron subvariants BA.4 and BA.5, which account for nearly all COVID-19 infections, could be available to the public in about six weeks, according to NPR. 
  • Drugmakers leap back into fading heart drug market

    As generics outpaced blood pressure and cholesterol medications, drugmakers initially withdrew from developing costly heart drugs but are now cautiously returning, The Wall Street Journal reported July 26.
  • Former pharmacy director at New Hampshire hospital where fentanyl went missing settles with state board

    Keene, N.H.-based Cheshire Medical Center's former pharmacy director, Melissa Siciliano, PharmD, must pay a $1,000 fine and participate in education courses as part of a settlement agreement reached with the state's pharmacy board July 20, The Keene Sentinel reported July 26. 
  • White House's vision for next-gen COVID-19 shots: 3 takeaways

    The White House held a summit on the next generation of COVID-19 vaccines July 26 during which federal health experts shared their vision for a vaccine that protects against infection from multiple variants, according to U.S. News & World Report.
  • Drugmaker organization launches ads lobbying against drug-pricing bill

    A lobbying group that represents drugmakers including Pfizer and Johnson & Johnson aired ads slamming the drug pricing bill trudging through Congress, The Hill reported July 25. 

Featured Learning Opportunities

Featured Whitepapers

Featured Webinars